Enanta Pharmaceuticals(ENTA) - 2023 Q4 - Earnings Call Presentation

Pharmaceuticals Great Chemistry Cures COVID-19: Phase 2 (SPRINT) complete A Proven Approach to Drug Discovery Proven Track Record of Success Strong Balance Sheet 3 | --- | --- | --- | |-------|-------|-------------------------------------------------------------------------------------------------| | | | | | HCV | HBV | viral infections Several therapeutic areas with goal of building multiple approaches in each | | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------|----------------|- ...